XRAY · trading date Oct 12, 2026 · previous close $8.84 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$3.68B
Net income
-$598.00M
Total assets
$5.43B
Total liabilities
$4.09B
Stockholders' equity
$1.34B
Cash & equivalents
$326.00M
Operating income
-$422.00M
Operating cash flow
$235.00M
Capital expenditures
$131.00M
Fiscal year 2025, via 10-K filed 2026-02-26.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-11.5%
Net margin
-16.3%
Free cash flow
$104.00M
Free cash flow margin
2.8%
Liabilities / assets
75.3%
Equity / assets
24.7%
CapEx / revenue
3.6%
Operating cash flow / net income
-0.39×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Charlotte, NC 28277-3607
13320 BALLANTYNE CORPORATE PLACE
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:48 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.